PROM1 and hepatocellular carcinoma: These interesting results were consistent with previous reports of certain crucial factors at the genomic level in CD133+ liver CSCs that differed from those in CD133- counterparts, which could explain the enhanced aggressive role of CD133+ cells in HCC [4].